Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1T14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $133,580
Award facts
- Contract value 100% obligated
- $133,580.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $133,580.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of January 7, 2026. This non-competitive delivery order was issued on January 6, 2026 and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, with delivery orders typically structured as firm fixed-price arrangements ranging from minimal to substantial values. This particular award for Enbrel, a biologic medication used in rheumatologic disease treatment, reflects the company's role in supplying specialty medications essential to military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1T14?
SPE2DR26F1T14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F1T14 worth?
The government has obligated $133,580 on SPE2DR26F1T14.
Is contract SPE2DR26F1T14 an order under another contract?
Yes. SPE2DR26F1T14 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T14 competed?
The extent of competition for SPE2DR26F1T14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award